Nipro Corporation (JP:8086)
:8086
Want to see JP:8086 full AI Analyst Report?
8086 Stock Chart & Stats
¥1502.50
-¥11.50(-0.77%)
At close: 4:00 PM EST
¥1502.50
-¥11.50(-0.77%)
Day’s Range― - ―
52-Week Range¥1,230.50 - ¥1,664.00
Previous CloseN/A
Volume329.50K
Average Volume (3M)504.50K
Market Cap
¥264.46B
Enterprise Value¥804.93B
Total Cash (Recent Filing)¥109.97B
Total Debt (Recent Filing)¥642.04B
Price to Earnings (P/E)18.7
Beta0.41
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.03%
Share Statistics
EPS (TTM)66.77
Shares Outstanding171,459,470
10 Day Avg. Volume391,050
30 Day Avg. Volume504,500
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)0.92
Price to Sales (P/S)0.38
P/FCF Ratio-32.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,500.00Price Target Upside-0.17% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)77.96
Revenue Forecast (FY)¥696.66B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables RevenueNipro’s product mix includes single-use clinical supplies and dialysis consumables that are consumed per treatment. This creates durable, repeatable revenue streams tied to chronic therapies and installed equipment, improving revenue visibility and resilience over multiple years.
Consistent Revenue GrowthSteady top-line expansion over several years indicates successful market penetration and scale. Growing revenue provides capacity to invest in manufacturing, R&D, and commercial coverage, enabling long-term competitiveness and potential operating leverage as the business scales.
Improving Operating Margin & Stable Gross MarginYear-over-year operating margin improvement and consistent gross margins signal better cost control and resilient product economics. Stable gross margins protect profitability against input volatility, while operating leverage from scale can support sustainable margin progress if maintained.
Bears Say
High LeverageElevated debt levels materially constrain financial flexibility and raise refinancing and interest-rate risk. Even with improvement from prior years, leverage at ~2.3x equity limits the company’s ability to absorb shocks, pursue opportunistic investments, or accelerate deleveraging without reducing operating investments.
Persistent Negative Free Cash FlowMulti-year negative free cash flow despite positive operating cash flow implies sustained investment or working-capital drag. This reduces capacity to pay down debt, fund dividends, or self-finance growth, increasing reliance on external funding and weakening the balance-sheet strengthening prospects.
Thin And Volatile Net MarginsLow and variable net margins leave limited earnings cushion against cost or pricing shocks and make profitability sensitive to cyclical or one-off items. This constrains the company’s ability to convert revenue growth into durable bottom-line improvement and cash available for deleveraging.
Nipro News
8086 FAQ
What was Nipro Corporation’s price range in the past 12 months?
Nipro Corporation lowest stock price was ¥1230.50 and its highest was ¥1664.00 in the past 12 months.
What is Nipro Corporation’s market cap?
Nipro Corporation’s market cap is ¥264.46B.
When is Nipro Corporation’s upcoming earnings report date?
Nipro Corporation’s upcoming earnings report date is Aug 07, 2026 which is in 82 days.
How were Nipro Corporation’s earnings last quarter?
Nipro Corporation released its earnings results on May 12, 2026. The company reported -¥19.5 earnings per share for the quarter, missing the consensus estimate of -¥16.014 by -¥3.486.
Is Nipro Corporation overvalued?
According to Wall Street analysts Nipro Corporation’s price is currently Overvalued.
Does Nipro Corporation pay dividends?
Nipro Corporation pays a Semiannually dividend of ¥18 which represents an annual dividend yield of 2.03%. See more information on Nipro Corporation dividends here
What is Nipro Corporation’s EPS estimate?
Nipro Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nipro Corporation have?
Nipro Corporation has 171,459,470 shares outstanding.
What happened to Nipro Corporation’s price movement after its last earnings report?
Nipro Corporation reported an EPS of -¥19.5 in its last earnings report, missing expectations of -¥16.014. Following the earnings report the stock price went down -0.68%.
Which hedge fund is a major shareholder of Nipro Corporation?
Currently, no hedge funds are holding shares in JP:8086
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nipro Corporation
Nipro Corporation (8086) is a global healthcare company headquartered in Japan, specializing in the development and manufacturing of medical devices, pharmaceuticals, and biotechnology. The company operates primarily in the areas of renal care, intravenous (IV) therapy, and blood transfusion, offering a wide range of products such as dialysis equipment, infusion systems, and various medical disposables. Nipro is committed to enhancing patient outcomes through innovative technologies and high-quality healthcare solutions.
8086 Stock 12 Month Forecast
Average Price Target
¥1,500.00
▼(-0.17% Downside)
Technical Analysis
Options Prices
Currently, No data available
---